For those that want a summary!
$Kiora Pharmaceuticals(KPRX.US$ NASDAQ: KPRX) entered into an agreement with Théa Open Innovation SAS (TOI) concerning the KIO-301 molecular photoswitch product. According to the agreement, Kiora Pharmaceuticals has granted TOI an exclusive, sublicensable license to pursue development, manufacturing, commercialization, and regulatory approvals for the product globally, excluding specific Asian countries. The focus of the product’s use will be on treating retinitis pigmentosa and/or other ophthalmological diseases.![]()
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only.
Read more
Comment
Sign in to post a comment
Jaguar8 : I always love medical stuff
TrytosaveabitOP Jaguar8: OMG yes! You know I do as well! Hehehe
Jaguar8 TrytosaveabitOP:
TrytosaveabitOP 73563107: The other platform I use doesn’t have PM
mizmo : I wouldn't be texting that guy. he seems volatile
TrytosaveabitOP 73563107: The tools were me telling you the proper way to use cost positioning and how to read a chart to know when to get in and out! The only trading tool is the chart and indicators
TrytosaveabitOP 73563107: SEC website to read 8K and every other filing! FDA PDUFA for IND and IMD!
Benjamin’s : Your thoughts on when to exit?
Benjamin’s Benjamin’s: Trytosaveabit, you still in or what’s your opinion thank you
TrytosaveabitOP Benjamin’s: Yes I am still in! I gave you my parameters for me to sell yesterday! So now I’m willing (. Very VERY uncommon for me to do this ) to wait until I’m 25% down! Then I may average down/sell at that point? Otherwise im holding for now
View more comments...